首页 › 基金 › Stonepine Capital Management, LLC › XERS

Stonepine Capital Management, LLC 对 XERS 的持仓历史

XERIS BIOPHARMA HOLDINGS INC · 医疗保健

Stonepine Capital Management, LLC 在 Q2 2026 的 13F 申报中披露持有 XERS(XERIS BIOPHARMA HOLDINGS INC)280,000 股,市值约 US$2.1M,约占其申报组合的 1.39%,在其申报持仓中市值排名第 24 位。 Stonepine Capital Management, LLC 最近 12 个申报季度中有 8 个季度披露了 XERS 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q2 2026)280.00K 股
申报持仓市值$2.10M
组合权重1.39%
首次申报Q3 2023
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Stonepine Capital Management, LLC 对 XERS 的持仓演变

Stonepine Capital Management, LLC 于 Q3 2023 首次披露 XERS 持仓:5,915,372 股(约 US$11.0M)。 该持仓在 Q4 2023 达到峰值 5,937,000 股,市值约 US$14.0M。 在 8 次申报中,Stonepine Capital Management, LLC 2 次增持、2 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 280,000 股、市值约 US$2.1M,环比增持 239,970 股。。 持仓曾出现大幅变动:Q1 2024 减持约 90% (随后一个季度股价上涨 2%)、Q2 2025 增持约 101% (随后一个季度股价上涨 74%)、Q2 2026 增持约 599% (随后一个季度股价上涨 21%)。

逐季持仓明细

季度股数金额变化
Q3 2023 5.92M $11.00M 新进
Q4 2023 5.94M $13.95M 持有
Q1 2024 598.09K $1.32M 减持
Q4 2024 182.32K $618.05K 新进
Q1 2025 102.27K $561.43K 减持
Q2 2025 205.10K $957.82K 增持
Q1 2026 40.03K $232.17K 新进
Q2 2026 280.00K $2.10M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 XERS 与 13F 数据

XERS(XERIS BIOPHARMA HOLDINGS INC)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 XERS,申报仓位最大的包括:CAPSTONE INVESTMENT ADVISORS, LLC (US$62.6M), Polar Asset Management Partners Inc. (US$28.8M), Rosalind Advisors, Inc. (US$23.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 XERS 的基金

查看 XERS 的全部基金持有人 →

常见问题

How long has Stonepine Capital Management, LLC held XERS?

Stonepine Capital Management, LLC has disclosed XERS holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

What is Stonepine Capital Management, LLC's current position in XERS?

As of Q2 2026, Stonepine Capital Management, LLC holds 280.00K shares of XERS (XERIS BIOPHARMA HOLDINGS INC), valued at $2.10M, representing 1.39% of its reported portfolio and ranking #24.

Has Stonepine Capital Management, LLC been buying or selling XERS?

In the latest 13F filing (Q2 2026), Stonepine Capital Management, LLC increased its position in XERS. The position peaked in Q4 2023 at 5.94M shares.

Which other funds hold XERS?

Other major institutional holders of XERS include CAPSTONE INVESTMENT ADVISORS, LLC, Polar Asset Management Partners Inc., Rosalind Advisors, Inc., among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.